COVID-19 Vaccine Recommendations to clinically eligible individuals. Supersedes AFL 22-09.1. Includes information related to updated COVID-19 vaccines.

COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. There is no preferential recommendation for the use of any one COVID-19 vaccine over another when more than one recommended and age-appropriate vaccine is available. The 2023–2024 formulation for all COVID-19 vaccines licensed or authorized in the United States (Moderna, Novavax, and Pfizer-BioNTech) has been updated to a monovalent vaccine based on the Omicron XBB.1.5 sublineage of SARS-CoV-2. The original monovalent and bivalent (Original and Omicron BA.4/BA.5) formulations should no longer be used.

Everyone should stay up to date with COVID-19 vaccines:

· Everyone 5 years of age and older is recommended to receive a single updated dose as long as it has been at least 2 months since their last dose. For assistance in obtaining COVID-19 vaccinations, MyTurn or CDC Vaccines. Vaccines available from COVID-19 vaccine manufacturers or wholesale distributors. Providers serving uninsured patients can inquire about participation in the Bridge Access Program.

Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.